Eli Lilly’s investment in new biopharma plant will be at least €1.2 billion
Amount that US pharma giant is investing in Limerick facility is much more than originally thought, as scale and fit-out of campus emerges
The full scale of Eli Lilly’s investment in a new biopharmaceutical manufacturing campus in Limerick will reach at least €1.2 billion, the Business Post can reveal.
The US pharma giant originally announced that the project would involve a €400 million investment and create 500 jobs, but senior industry sources have confirmed that it is much more significant in scale.
First announced in January this year, Eli Lilly plans to build a state-of-the-art biopharma manufacturing facility ...